Exact Mass: 440.2311102

Exact Mass Matches: 440.2311102

Found 141 metabolites which its exact mass value is equals to given mass value 440.2311102, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tirofiban

(2S)-2-(butane-1-sulfonamido)-3-{4-[4-(piperidin-4-yl)butoxy]phenyl}propanoic acid

C22H36N2O5S (440.23448060000004)


Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-[2-[[(1S,2R,3S)-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid

3-[2-[[(1S,2R,3S)-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid

C25H32N2O5 (440.2311102)


   

Nemiralisib

6-(1H-indol-4-yl)-4-(5-((4-(1-Methylethyl)-1-piperazinyl)methyl)-1,3-oxazol-2-yl)-1H-indazole

C26H28N6O (440.2324478)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System

   
   

Cryptoporic acid B

(+)-Cryptoporic acid B

C23H36O8 (440.2410056)


   
   

linalool-beta-D-glucopyranoside-2O-acetate,6O-tiglate

linalool-beta-D-glucopyranoside-2O-acetate,6O-tiglate

C23H36O8 (440.2410056)


   
   

Obscurinervine, dihydro-

Obscurinervine, dihydro-

C25H32N2O5 (440.2311102)


   

methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranoside]|Methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranosid]

methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranoside]|Methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranosid]

C19H36O11 (440.22575059999997)


   

(3S,4R)-4-([(1S,4aR,6S,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylidenenaphthalen-1-yl]-methoxy)-5-methoxy-3-(methoxycarbonyl)-5-oxopentanoic acid|cryptoporic acid J

(3S,4R)-4-([(1S,4aR,6S,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylidenenaphthalen-1-yl]-methoxy)-5-methoxy-3-(methoxycarbonyl)-5-oxopentanoic acid|cryptoporic acid J

C23H36O8 (440.2410056)


   

cyclo(N8-(alpha,alpha-dimethylallyl)-L-Trp-L-Trp)

cyclo(N8-(alpha,alpha-dimethylallyl)-L-Trp-L-Trp)

C27H28N4O2 (440.2212148)


   
   
   

C27H28N4O2_(3S,6S)-3-(1H-Indol-3-ylmethyl)-6-{[2-(2-methyl-3-buten-2-yl)-1H-indol-3-yl]methyl}-2,5-piperazinedione

NCGC00385485-01_C27H28N4O2_(3S,6S)-3-(1H-Indol-3-ylmethyl)-6-{[2-(2-methyl-3-buten-2-yl)-1H-indol-3-yl]methyl}-2,5-piperazinedione

C27H28N4O2 (440.2212148)


   

C19H36O11_beta-D-Glucopyranoside, 3-ethyl-4-hydroxy-4-methylpentyl 6-O-[(2S,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]

NCGC00384694-01_C19H36O11_beta-D-Glucopyranoside, 3-ethyl-4-hydroxy-4-methylpentyl 6-O-[(2S,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]-

C19H36O11 (440.22575059999997)


   

Ala His Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Ala His Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Ala His Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Ala His Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Ala Ile His Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Ala Ile Thr His

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Ala Leu His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Ala Leu Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Ala Thr His Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Ala Thr His Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Ala Thr Ile His

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Ala Thr Leu His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Asp Ile Pro Pro

(2S)-1-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Asp Leu Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Asp Pro Ile Pro

(2S)-1-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Asp Pro Leu Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Asp Pro Pro Ile

(2S,3S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H32N4O7 (440.22708819999997)


   

Asp Pro Pro Leu

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H32N4O7 (440.22708819999997)


   

Glu Pro Pro Val

(4S)-4-amino-5-[(2S)-2-{[(2S)-2-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pyrrolidin-1-yl]carbonyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C20H32N4O7 (440.22708819999997)


   

Glu Pro Val Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Glu Val Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

His Ala Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

His Ala Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

His Ala Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

His Ala Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

His Ile Ala Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

His Ile Thr Ala

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxybutanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

His Leu Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

His Leu Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxybutanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

His Ser Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-methylbutanamido]-3-methylbutanoic acid

C19H32N6O6 (440.2383212)


   

His Thr Ala Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]propanamido]-3-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

His Thr Ala Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]propanamido]-4-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

His Thr Ile Ala

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylpentanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

His Thr Leu Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-methylpentanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

His Val Ser Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C19H32N6O6 (440.2383212)


   

His Val Val Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C19H32N6O6 (440.2383212)


   

Ile Ala His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Ile Ala Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Ile Asp Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Ile His Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Ile His Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Ile Pro Asp Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Ile Pro Pro Asp

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanedioic acid

C20H32N4O7 (440.22708819999997)


   

Ile Thr Ala His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Ile Thr His Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Leu Ala His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Leu Ala Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Leu Asp Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Leu His Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxybutanoic acid

C19H32N6O6 (440.2383212)


   

Leu His Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Leu Pro Asp Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Leu Pro Pro Asp

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanedioic acid

C20H32N4O7 (440.22708819999997)


   

Leu Thr Ala His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Leu Thr His Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Pro Asp Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Pro Asp Leu Pro

(2S)-1-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Pro Asp Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H32N4O7 (440.22708819999997)


   

Pro Asp Pro Leu

(2S)-2-{[(2S)-1-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H32N4O7 (440.22708819999997)


   

Pro Glu Pro Val

(4S)-5-[(2S)-2-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pyrrolidin-1-yl]-5-oxo-4-[(2S)-pyrrolidin-2-ylformamido]pentanoic acid

C20H32N4O7 (440.22708819999997)


   

Pro Glu Val Pro

(2S)-1-[(2S)-2-[(2S)-4-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Pro Ile Asp Pro

(2S)-1-[(2S)-3-carboxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Pro Ile Pro Asp

(2S)-2-{[(2S)-1-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C20H32N4O7 (440.22708819999997)


   

Pro Leu Asp Pro

(2S)-1-[(2S)-3-carboxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Pro Leu Pro Asp

(2S)-2-{[(2S)-1-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C20H32N4O7 (440.22708819999997)


   

Pro Pro Asp Ile

(2S,3S)-2-[(2S)-3-carboxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C20H32N4O7 (440.22708819999997)


   

Pro Pro Asp Leu

(2S)-2-[(2S)-3-carboxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C20H32N4O7 (440.22708819999997)


   

Pro Pro Glu Val

(4S)-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-4-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanoic acid

C20H32N4O7 (440.22708819999997)


   

Pro Pro Ile Asp

(2S)-2-[(2S,3S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]butanedioic acid

C20H32N4O7 (440.22708819999997)


   

Pro Pro Leu Asp

(2S)-2-[(2S)-4-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]butanedioic acid

C20H32N4O7 (440.22708819999997)


   

Pro Pro Val Glu

(2S)-2-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]pentanedioic acid

C20H32N4O7 (440.22708819999997)


   

3-HydroxyPravastatin

3-HydroxyPravastatin

C23H36O8 (440.2410056)


   

Pro Val Glu Pro

(2S)-1-[(2S)-4-carboxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Pro Val Pro Glu

(2S)-2-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C20H32N4O7 (440.22708819999997)


   

Ser His Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C19H32N6O6 (440.2383212)


   

Ser Val His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C19H32N6O6 (440.2383212)


   

Ser Val Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Thr Ala His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Thr Ala His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Thr Ala Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Thr Ala Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Thr His Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Thr His Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanoic acid

C19H32N6O6 (440.2383212)


   

Thr His Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Thr His Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Thr Ile Ala His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Thr Ile His Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Thr Leu Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Thr Leu His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C19H32N6O6 (440.2383212)


   

Val Glu Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Val His Ser Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C19H32N6O6 (440.2383212)


   

Val His Val Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C19H32N6O6 (440.2383212)


   

Val Pro Glu Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C20H32N4O7 (440.22708819999997)


   

Val Pro Pro Glu

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanedioic acid

C20H32N4O7 (440.22708819999997)


   

Val Ser His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C19H32N6O6 (440.2383212)


   

Val Ser Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

Val Val His Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C19H32N6O6 (440.2383212)


   

Val Val Ser His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C19H32N6O6 (440.2383212)


   

1-(2-(DI-TERT-BUTYLPHOSPHINO)PHENYL)-3,5-DIPHENYL-1H-PYRAZOLE

1-(2-(DI-TERT-BUTYLPHOSPHINO)PHENYL)-3,5-DIPHENYL-1H-PYRAZOLE

C29H33N2P (440.23812280000004)


   

TRIS(DIETHYLAMINO)(ETHYLIMINO)TANTALUM(&

TRIS(DIETHYLAMINO)(ETHYLIMINO)TANTALUM(&

C14H35N4Ta (440.234171)


   
   

Ifetroban

Ifetroban

C25H32N2O5 (440.2311102)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

RU 28318, potassium salt

RU 28318, potassium salt

C25H37KO4 (440.2328782)


   

BIX 02189

(Z)-3-((3-((dimethylamino)methyl)phenylamino)(phenyl)methylene)-N,N-dimethyl-2-oxoindoline-6-carboxamide

C27H28N4O2 (440.2212148)


BIX02189 is a potent and selective MEK5 inhibitor with an IC50 of 1.5 nM. BIX02189 also inhibits ERK5 catalytic activity with an IC50 of 59 nM.

   

Trans-1-[4-(4-heptylcyclohexyl)phenoxy]-2,4-dinitro benzene

Trans-1-[4-(4-heptylcyclohexyl)phenoxy]-2,4-dinitro benzene

C25H32N2O5 (440.2311102)


   

1-N,4-N-bis(4-methylphenyl)-1-N,4-N-diphenylbenzene-1,4-diamine

1-N,4-N-bis(4-methylphenyl)-1-N,4-N-diphenylbenzene-1,4-diamine

C32H28N2 (440.2252368)


   
   

Methyl-[4-(4-piperidine-1-ylmethyl-phenyl)-cyclohexyl]-carbaminic acid-(4-chlorophenyl)-ester

Methyl-[4-(4-piperidine-1-ylmethyl-phenyl)-cyclohexyl]-carbaminic acid-(4-chlorophenyl)-ester

C26H33ClN2O2 (440.22304280000003)


   

Nemiralisib

Nemiralisib

C26H28N6O (440.2324478)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System

   

Macrophylline B

Macrophylline B

C25H32N2O5 (440.2311102)


A natural product found in Uncaria macrophylla.

   

Macrophylline A

Macrophylline A

C25H32N2O5 (440.2311102)


A natural product found in Uncaria macrophylla.

   

Dihydroouabagenin

Dihydroouabagenin

C23H36O8 (440.2410056)


   

methyl (1R,9S,10S,11S)-12-(cyclohexanecarbonyl)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate

methyl (1R,9S,10S,11S)-12-(cyclohexanecarbonyl)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C25H32N2O5 (440.2311102)


   

Tirofiban

Tirofiban

C22H36N2O5S (440.23448060000004)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

cPA(20:4)

cPA(20:4)

C23H37O6P (440.2327632)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved